Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1991

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Favorable effects of oral estrogen-progestin contraception. [Priznive

pusobeni oralni estrogen-progestinove kontracepce.]

AUTHORS

Presl J

SOURCE

CESKOSLOVENSKA GYNEKOLOGIE. 1991 Nov;56(5-6):350-2.

ABSTRACT

The beneficial effects of combined estrogen-progestin-containing oral contraceptives (OCs) include prevention of

pregnancy (less than 1 failure out of 100 regular users); the prevention of ectopic pregnancy; the reduction of

preeclampsia (2.4 times lower risk compared with barrier methods); and reduction of pelvic inflammation to about

one-half. The effects on menstruation include the reduction of sideropenic anemia (by lowering the incidence and

duration of menstruation, OCs reduce the loss of iron to 50% or to as much as 33%); dysmenorrhea by 40%

(symptoms receded in 90% of users); and premenstrual syndrome by 30%. OCs exert a favorable effect on menstrual

epilepsy; reduce sports-related accidents in the premenstrual and menstrual periods; and reduce intermenstrual

bleeding. The protection from cancer includes the lowering of endometrial cancer risk (every 2 years of use reduces

the risk by 38%, 12 years of use by 70%, and the beneficial effects last 3-15 years); reduction of the risk of the ovarian

cancer (already 3-6 months of use reduces the risk by 30%, and more than 5 years by 50% in women under 50 years

of age with a longterm effect of 10 years or more, which drops sharply in women over 60 who are mostly at risk).

Among other beneficial effects, they reduce benign mastopathy by 50-75%; reduce the risk of follicular ovarian cysts

to 50% and the risk of corpus luteal ovarian cysts to 1/5; and they lessen bone loss which favorably affects

osteoporosis. Low-dose OCs minimize the well-known risks of thrombotic and cerebrovascular accidents, myocardial

infarction, hypertension, altered carbohydrate metabolism, gallbladder diseases, and liver cancer. A new OC with 30

mcg of ethinyl estradiol was tested with daily doses of 150 mcg of desogestrel. The high density lipoprotein (HDL)

either increased or did not change with desogestrel: the HDL2 subfraction that protects from atherosclerosis did not

change, and probably the HDL3 raised the HDL level. (PubHealth.info Document ID: CONT3T 2507-06)

PubHealth.info NOTE: The author(s) of this article titled, "Favorable effects of oral estrogen-progestin contraception.

[Priznive pusobeni oralni estrogen-progestinove kontracepce.]", is(are) Presl J. The source of this article is

"CESKOSLOVENSKA GYNEKOLOGIE. 1991 Nov;56(5-6):350-2.". This article was published in 1991 in Czech

language(s). (PubHealth.info® Document ID: CONT3T 2507-06. All rights reserved with PubHealth.info) PIN: 12507

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.